programmed hematopoietic cells (Fate Therapeutics)

N/A

Report date: 2025/01/26 16:53:12

Base Information

Drug Nameprogrammed hematopoietic cells (Fate Therapeutics)
Drug Alias Nameprogrammed T-cells (Fate Therapeutics)FT-1050 programmed CD34+ cells (Fate Therapeutics)programmed CD34+ cells (Fate Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionHematopoietic progenitor cell antigen CD34 modulators
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFate Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFate Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A